A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome

A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome

Clozapine is the only medication approved for treatment-resistant schizophrenia. Clozapine toxicity associated with COVID-19 infection could be amplified by concomitant nirmatrelvir/ritonavir. Knowledge gaps among clinicians and patients led to patient safety concerns and the implementation of a qua...

Full description

Saved in:
Bibliographic Details
Main Authors: Monica Fahmy, PharmD, Youssef Bessada, PharmD, Cassandra Ramsey, APRN, Jennifer R. Zigun, MD
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2025-04-01
Series:Mental Health Clinician
Subjects:
brugada syndrome
antipsychotics
depression
drug-disease interactions
aripiprazole
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2025.04.062
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items